Lymphoma & Leukaemia Research Review Issue 104
In this issue:
Outcomes of ASCT plus ibrutinibcontaining regimens
Is FL curable with standard chemoimmunotherapy?
Efficacy and safety of nilotinib plus Peg-IFN alfa-2a
LymphoVista and monitoring lymphoma
Efficacy of ipilimumab plus BV and nivolumab
Prognostic performance of MALT-IPI
Efficacy of zanubrutinib versus acalabrutinib plus venetoclax
Tolerability and efficacy of mosunetuzumab
Survival trends of advanced-stage MCL
Addressing treatment resistance and intolerance among CLL patients
Expert contributor
Dr Monique Menzies Wojtowicz
Dr Monique Menzies Wojtowicz is a haematologist at Macquarie University Hospital and Scientia Clinical Research. She is interested in lymphoma, CLL, transfusion and medical education and delivering the best care to patients via clinical trials research. She was an Early Career Clinician Researcher with the ALLG for 2023-2024 and is a member of the ALLG […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.